Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation
about
Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutationsMicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for TreatmentSecond- and third-generation ALK inhibitors for non-small cell lung cancerRecent advances of highly selective CDK4/6 inhibitors in breast cancerModification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer.Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trialMicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A/Wnt signaling pathway.Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.Croton Tiglium Extract Induces Apoptosis via Bax/Bcl-2 Pathways in Human Lung Cancer A549 CellsEmerging role of microRNA-21 in cancer.MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact.Predictive value of microRNA-143 in evaluating the prognosis of patients with hepatocellular carcinoma.Plasma microRNA alterations between EGFR-activating mutational NSCLC patients with and without primary resistance to TKI.Predictive relevance of miR-34a, miR-224 and miR-342 in patients with advanced squamous cell carcinoma of the lung undergoing palliative chemotherapy.miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.Exosome-mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR-21.
P2860
Q26744339-49392400-B76A-4852-A811-B2291B309F22Q26752548-AC7A3E8F-756B-4F9F-AF2E-980BA6170C01Q28072496-C27D5AF7-8C22-4ED9-B566-6F9045525CFEQ33602076-9C5FC677-5CD5-460D-85BB-D2AA0C07416EQ37233557-879C47BB-8603-44CC-BEB9-662003A06D57Q37251422-E536AE87-867F-4199-B614-C234CDA17043Q38604500-D12816C5-9014-4F68-A99B-A4FBF40A7C8EQ38710426-09E2D885-2E0D-4135-9ED8-156AE62279BAQ38723876-C4585481-E371-4310-B9A7-C8AF560251C2Q38971467-8ADA31FB-5308-4828-A4D6-482D5445FA8AQ39433270-A291996D-D115-4213-BD27-EB553E16641BQ40240424-1D2F1401-CB13-424A-B965-6D534350BC87Q47098762-B73E47D4-73B8-4F08-8593-AA66A276A3C7Q49277521-5470DC4B-82C2-4AEE-9822-E61A98A468A9Q53189857-DE93283C-C831-4327-8793-1ED3AF7EFEDAQ55408017-F150C275-705D-4198-85FE-97DA3597E147
P2860
Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Identification of plasma micro ...... with EGFR activating mutation
@ast
Identification of plasma micro ...... with EGFR activating mutation
@en
type
label
Identification of plasma micro ...... with EGFR activating mutation
@ast
Identification of plasma micro ...... with EGFR activating mutation
@en
prefLabel
Identification of plasma micro ...... with EGFR activating mutation
@ast
Identification of plasma micro ...... with EGFR activating mutation
@en
P2093
P2860
P1476
Identification of plasma micro ...... with EGFR activating mutation
@en
P2093
Jianchun Duan
Shuhang Wang
Tongtong An
Xiaomei Su
Zhenxiang Li
Zhijie Wang
P2860
P2888
P356
10.1186/S13045-015-0210-9
P577
2015-11-12T00:00:00Z
P5875
P6179
1024833127